CSafe Global, the only provider of both active and passive temperature-controlled packaging solutions for the transport of life-enhancing biopharmaceuticals, is has announced the launch of its new CSafe AcuTemp Plus Series.

Today, CSafe is expanding its passive packaging portfolio with the launch of the new AcuTemp Plus Series to address the cold chain needs of commercial pharma, clinical trials, and cell and gene therapies. With high-performing Vacuum Insulated Panels (VIP) and single temperature phase change material (PCM), this enhanced series is optimally designed for performance, simplicity and efficiency.

“The AcuTemp Plus Series has been developed with our customers in mind, offering them the level of performance and quality they expect, while delivering the peace of mind they deserve,” stated Patrick Schafer, CEO of CSafe Global.